Qliro Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Qliro şirketinin toplam varlıkları SEK3.5B ve toplam özkaynağı SEK487.4M dır. Toplam mevduat SEK2.7B ve toplam krediler SEK2.5B dır.

Anahtar bilgiler

7.1x

Varlık/özkaynak oranı

n/a

Net faiz marjı

Toplam mevduat	SEK 2.71b
Kredi/mevduat oranı	Uygun
Batık krediler	8.8%
Sorunlu krediler için ayrılan karşılık	Düşük
Cari oran	Düşük
Nakit ve eşdeğerleri	SEK 119.70m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

When Will Qliro AB (publ) (STO:QLIRO) Breakeven?

Feb 19

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: QLIRO 'nin Varlık/Özsermaye oranı ( 7.1 x) düşüktür.

Kötü Krediler İçin Ödenek: QLIRO düşük kötü krediler için ödeneke sahiptir ( 69 %).

Düşük Riskli Yükümlülükler: QLIRO 'un yükümlülüklerinin 91% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: QLIRO Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 72% ).

Düşük Riskli Mevduatlar: QLIRO 'nin Kredi/Mevduat oranı ( 93% ) uygundur.

Kötü Kredilerin Seviyesi: QLIRO yüksek düzeyde kötü kredi içeriyor ( 8.8 %).

Qliro Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

New minor risk - Shareholder dilution

Investor sentiment improves as stock rises 17%

Chief Executive Officer recently bought kr3.5m worth of stock

Chief Executive Officer recently bought kr393k worth of stock

Second quarter 2024 earnings released: EPS: kr0.18 (vs kr0.042 in 2Q 2023)

Investor sentiment improves as stock rises 15%

Consensus EPS estimates fall by 12%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Chief Executive Officer recently bought kr177k worth of stock

Full year 2023 earnings released: EPS: kr0.21 (vs kr4.90 loss in FY 2022)

Forecast breakeven date pushed back to 2024

Third quarter 2023 earnings released: EPS: kr0.037 (vs kr1.18 loss in 3Q 2022)

Qliro AB (publ) to Report Q2, 2024 Results on Jul 17, 2024

Qliro AB Announces Nomination Committee

Chief Executive Officer recently bought kr470k worth of stock

Qliro AB (publ) to Report Fiscal Year 2023 Results on Feb 08, 2024

Second quarter 2023 earnings released: EPS: kr0.042 (vs kr1.53 loss in 2Q 2022)

Chief Executive Officer recently bought kr219k worth of stock

Chief Executive Officer recently bought kr341k worth of stock

Chief Executive Officer recently bought kr252k worth of stock

Independent Director recently bought kr81k worth of stock

First quarter 2023 earnings released: EPS: kr0.058 (vs kr0.40 loss in 1Q 2022)

Chief Executive Officer recently bought kr1.1m worth of stock

Full year 2022 earnings released: kr4.90 loss per share (vs kr2.22 loss in FY 2021)

Qliro AB (publ) to Report Fiscal Year 2022 Results on Feb 08, 2023

Chief Executive Officer recently bought kr264k worth of stock

Chief Financial Officer recently bought kr395k worth of stock

Price target decreased to kr19.00

Qliro AB (Publ) Announces Executive Changes

Third quarter 2022 earnings released: kr1.18 loss per share (vs kr0.45 loss in 3Q 2021)

Qliro AB (publ) announced that it has received SEK 1.54 million in funding

Consensus EPS estimates fall by 214%

Second quarter 2022 earnings released: kr1.53 loss per share (vs kr0.68 loss in 2Q 2021)

Qliro AB (Publ) Announces CEO Changes, Effective from October 1, 2022

Qliro AB (publ) Approves New Board Appointments

First quarter 2022 earnings: EPS exceeds analyst expectations

Consensus EPS estimates fall by 15%

Price target decreased to kr25.00

Full year 2021 earnings: EPS misses analyst expectations

No longer forecast to breakeven

Third quarter 2021 earnings released: kr0.45 loss per share (vs kr0.87 loss in 3Q 2020)

Independent Chairman of the Board recently bought kr161k worth of stock

Second quarter 2021 earnings released

No longer forecast to breakeven

Forecast to breakeven in 2023

When Will Qliro AB (publ) (STO:QLIRO) Breakeven?

New 90-day high: kr49.55

New 90-day high: kr39.45

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Sağlıklı şirketleri keşfedin